Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,294 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
NK4, an HGF antagonist, prevents hematogenous pulmonary metastasis by inhibiting adhesion of CT26 cells to endothelial cells.
Kubota T, Taiyoh H, Matsumura A, Murayama Y, Ichikawa D, Okamoto K, Fujiwara H, Ikoma H, Nakanishi M, Kikuchi S, Sakakura C, Ochiai T, Kokuba Y, Taniguchi H, Sonoyama T, Matsumoto K, Nakamura T, Otsuji E. Kubota T, et al. Among authors: murayama y. Clin Exp Metastasis. 2009;26(5):447-56. doi: 10.1007/s10585-009-9244-0. Epub 2009 Feb 21. Clin Exp Metastasis. 2009. PMID: 19234748
Gene transfer of NK4, an angiogenesis inhibitor, induces CT26 tumor regression via tumor-specific T lymphocyte activation.
Kubota T, Taiyoh H, Matsumura A, Murayama Y, Ichikawa D, Okamoto K, Fujiwara H, Ikoma H, Nakanishi M, Kikuchi S, Ochiai T, Sakakura C, Kokuba Y, Sonoyama T, Suzuki Y, Matsumoto K, Nakamura T, Otsuji E. Kubota T, et al. Among authors: murayama y. Int J Cancer. 2009 Dec 15;125(12):2879-86. doi: 10.1002/ijc.24735. Int J Cancer. 2009. PMID: 19588506
HGF regulates VEGF expression via the c-Met receptor downstream pathways, PI3K/Akt, MAPK and STAT3, in CT26 murine cells.
Matsumura A, Kubota T, Taiyoh H, Fujiwara H, Okamoto K, Ichikawa D, Shiozaki A, Komatsu S, Nakanishi M, Kuriu Y, Murayama Y, Ikoma H, Ochiai T, Kokuba Y, Nakamura T, Matsumoto K, Otsuji E. Matsumura A, et al. Among authors: murayama y. Int J Oncol. 2013 Feb;42(2):535-42. doi: 10.3892/ijo.2012.1728. Epub 2012 Dec 6. Int J Oncol. 2013. PMID: 23233163
Interruption of the HGF paracrine loop by NK4, an HGF antagonist, reduces VEGF expression of CT26 cells.
Kubota T, Matsumura A, Taiyoh H, Izumiya Y, Fujiwara H, Okamoto K, Ichikawa D, Shiozaki A, Komatsu S, Nakanishi M, Kuriu Y, Murayama Y, Ikoma H, Ochiai T, Nakamura T, Matsumoto K, Nakamura T, Otsuji E. Kubota T, et al. Among authors: murayama y. Oncol Rep. 2013 Aug;30(2):567-72. doi: 10.3892/or.2013.2509. Epub 2013 May 29. Oncol Rep. 2013. PMID: 23722408
Optimal surgical treatment for patients with pT2 gallbladder cancer.
Harada K, Ochiai T, Inoue K, Soga K, Murayama Y, Komatsu S, Shiozaki A, Kuriu Y, Ikoma H, Nakanishi M, Ichikawa D, Fujiwara H, Okamoto K, Kokuba Y, Sonoyama T, Otsuji E. Harada K, et al. Among authors: murayama y. Hepatogastroenterology. 2011 Jan-Feb;58(105):14-9. Hepatogastroenterology. 2011. PMID: 21510279
Prognostic impact of cancer-related symptoms in recurrent gastric cancer patients.
Kosuga T, Ichikawa D, Komatsu S, Okamoto K, Fujiwara H, Murayama Y, Kuriu Y, Ikoma H, Nakanishi M, Ochiai T, Shiozaki A, Kokuba Y, Sonoyama T, Otsuji E. Kosuga T, et al. Among authors: murayama y. Hepatogastroenterology. 2011 Jan-Feb;58(105):213-7. Hepatogastroenterology. 2011. PMID: 21510317
Long-term survivors of esophageal carcinoma with distant lymph node metastasis.
Okamura S, Fujiwara H, Shiozaki A, Komatsu S, Ichikawa D, Okamoto K, Murayama Y, Ikoma H, Kuriu Y, Nakanishi M, Ochiai T, Kokuba Y, Sonoyama T, Otsuji E. Okamura S, et al. Among authors: murayama y. Hepatogastroenterology. 2011 Mar-Apr;58(106):421-5. Hepatogastroenterology. 2011. PMID: 21661407
1,294 results